Law360, Washington (March 28, 2014, 5:54 PM EDT) -- The Federal Trade Commission has a full agenda for 2014 including a patent troll study and hospital merger challenges, but what's at the top of the watchdog’s wish list? “A billion-dollar settlement” in one of its pay-for-delay cases, the head of the Bureau of Competition quipped Friday.
The FTC’s long-running battle to block reverse payment Hatch-Waxman Act settlements remains a top priority for the agency, bureau director Debbie Feinstein said at the American Bar Association Antitrust Section’s spring meeting. And after more than a decade of fighting with drugmakers over whether the patent settlements can even be reviewed under the antitrust...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!